BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 20545324)

  • 1. The N-terminal integrity is critical for the stability and biological functions of endostatin.
    Fu Y; Luo Y
    Biochemistry; 2010 Aug; 49(30):6420-9. PubMed ID: 20545324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unraveling the mysteries of endostatin.
    Fu Y; Tang H; Huang Y; Song N; Luo Y
    IUBMB Life; 2009 Jun; 61(6):613-26. PubMed ID: 19472178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zinc-binding of endostatin is essential for its antiangiogenic activity.
    Boehm T; O'reilly MS; Keough K; Shiloach J; Shapiro R; Folkman J
    Biochem Biophys Res Commun; 1998 Nov; 252(1):190-4. PubMed ID: 9813168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 27-amino-acid synthetic peptide corresponding to the NH2-terminal zinc-binding domain of endostatin is responsible for its antitumor activity.
    Tjin Tham Sjin RM; Satchi-Fainaro R; Birsner AE; Ramanujam VM; Folkman J; Javaherian K
    Cancer Res; 2005 May; 65(9):3656-63. PubMed ID: 15867360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-terminal fragment of the anti-angiogenic human endostatin binds copper(II) with very high affinity.
    Kolozsi A; Jancsó A; Nagy NV; Gajda T
    J Inorg Biochem; 2009 Jul; 103(7):940-7. PubMed ID: 19447499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of the KEX1 gene in Pichia pastoris allows expression of full-length murine and human endostatin.
    Boehm T; Pirie-Shepherd S; Trinh LB; Shiloach J; Folkman J
    Yeast; 1999 May; 15(7):563-72. PubMed ID: 10341419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-/C-terminal deleted mutant of human endostatin efficiently acts as an anti-angiogenic and anti-tumorigenic agent.
    Cho H; Kim WJ; Lee YM; Kim YM; Kwon YG; Park YS; Choi EY; Kim KW
    Oncol Rep; 2004 Jan; 11(1):191-5. PubMed ID: 14654925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contributions of Zn(II)-binding to the structural stability of endostatin.
    Han Q; Fu Y; Zhou H; He Y; Luo Y
    FEBS Lett; 2007 Jun; 581(16):3027-32. PubMed ID: 17544408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural analysis of the N-terminal fragment of the antiangiogenic protein endostatin: a molecular dynamics study.
    Torres PH; Sousa GL; Pascutti PG
    Proteins; 2011 Sep; 79(9):2684-92. PubMed ID: 21769939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inhibition effect in vitro of purified endostatin expressed in Pichia pastoris].
    Feng Y; Cui LB; Liu CX; Ma QJ
    Sheng Wu Gong Cheng Xue Bao; 2001 May; 17(3):278-82. PubMed ID: 11517600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High level expression of human endostatin in Pichia pastoris using a synthetic gene construct.
    Su Z; Wu X; Feng Y; Ding C; Xiao Y; Cai L; Feng W; Li X
    Appl Microbiol Biotechnol; 2007 Jan; 73(6):1355-62. PubMed ID: 17115211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The heparin binding motif of endostatin mediates its interaction with receptor nucleolin.
    Fu Y; Chen Y; Luo X; Liang Y; Shi H; Gao L; Zhan S; Zhou D; Luo Y
    Biochemistry; 2009 Dec; 48(49):11655-63. PubMed ID: 19877579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of the conserved first 18 N-terminal amino acid residues in rat liver carnitine palmitoyltransferase I abolishes malonyl-CoA sensitivity and binding.
    Shi J; Zhu H; Arvidson DN; Cregg JM; Woldegiorgis G
    Biochemistry; 1998 Aug; 37(31):11033-8. PubMed ID: 9692998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acid-induced unfolding mechanism of recombinant human endostatin.
    Li B; Wu X; Zhou H; Chen Q; Luo Y
    Biochemistry; 2004 Mar; 43(9):2550-7. PubMed ID: 14992592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endostatin phenylalanines 31 and 34 define a receptor binding site.
    Stahl S; Gaetzner S; Mueller TD; Felbor U
    Genes Cells; 2005 Sep; 10(9):929-39. PubMed ID: 16115201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineering of a disulfide loop instead of a Zn binding loop restores the anti-proliferative, anti-angiogenic and anti-tumor activities of the N-terminal fragment of endostatin: Mechanistic and therapeutic insights.
    Chamani R; Asghari SM; Alizadeh AM; Eskandari S; Mansouri K; Khodarahmi R; Taghdir M; Heidari Z; Gorji A; Aliakbar A; Ranjbar B; Khajeh K
    Vascul Pharmacol; 2015 Sep; 72():73-82. PubMed ID: 26187352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble multimer of recombinant endostatin expressed in E. coli has anti-angiogenesis activity.
    Wei DM; Gao Y; Cao XR; Zhu NC; Liang JF; Xie WP; Zhen MY; Zhu MS
    Biochem Biophys Res Commun; 2006 Jul; 345(4):1398-404. PubMed ID: 16723120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The minimal active domain of endostatin is a heparin-binding motif that mediates inhibition of tumor vascularization.
    Olsson AK; Johansson I; Akerud H; Einarsson B; Christofferson R; Sasaki T; Timpl R; Claesson-Welsh L
    Cancer Res; 2004 Dec; 64(24):9012-7. PubMed ID: 15604266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of biologically active endostatin fragments from human collagen XVIII by distinct matrix metalloproteases.
    Heljasvaara R; Nyberg P; Luostarinen J; Parikka M; Heikkilä P; Rehn M; Sorsa T; Salo T; Pihlajaniemi T
    Exp Cell Res; 2005 Jul; 307(2):292-304. PubMed ID: 15950618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulfate stabilizes the folding intermediate more than the native structure of endostatin.
    Fu Y; Wu X; Han Q; Liang Y; He Y; Luo Y
    Arch Biochem Biophys; 2008 Mar; 471(2):232-9. PubMed ID: 18182153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.